Current Research

Listed below is a description of our ongoing research projects.

If you are interested in participating in one of our projects that are currently recruiting participants, click on the link below the respective project which will take you to a pre-screening survey that we will use to help determine your eligibility for the project.

Please note that none of our current studies provide monetary compensation for participation.

If you are interested in more information about one of the studies listed here and would like to speak with a researcher please call: (512) 814-5480

  • This treatment study investigates the relative clinical efficacy of 300 mg. of pure hemp-derived CBD isolate, 300 mg. of full-spectrum CBD oil, 300 mg. of broad-spectrum CBD oil, or Placebo oil among adults presenting with COVID-19 – induced anxiety, depression, or sleep disturbance.

    If you’d like to learn about our study requirements and determine your eligibility, please complete the screening survey below.

  • This treatment study investigates the relative clinical efficacy of 300 mg. of pure hemp-derived CBD isolate, 300 mg. of full-spectrum CBD oil, 300 mg. of broad-spectrum CBD oil, or Placebo oil among adults presenting with COVID-19 – induced anxiety, depression, or sleep disturbance.

    If you’d like to learn about our study requirements and determine your eligibility, please complete the screening survey below.

  • Are you currently experiencing flashbacks, nightmares, sleep problems, anxiety, or avoiding places or situations resulting from a traumatic event such as a serious car accident, sexual or physical assault, or combat experience?

    If so, you may be eligible to take part in a University of Texas study testing several online strategies for reducing trauma-related symptoms.

    If you qualify for the study, you may receive the following at no cost (all online):

    • a psychological evaluation
    • an intervention for reducing trauma-related symptoms
    • and a 1-month follow-up assessment
  • This study aims to test whether cannabidiol (CBD) can reduce fear of anxiety-related bodily sensations by disrupting fear memory reconsolidation.

  • This study will examine the use of memory reconsolidation disruption and psychoeducation for the prevention of PTSD following a traumatic event. Individuals who present to a hospital emergency room for a traumatic event will be provided with the option to enroll in this study. Several hospitals in Texas will be participating.

    Not currently recruiting participants.